Metabolites (Jun 2022)

Serum and Soleus Metabolomics Signature of <i>Klf10</i> Knockout Mice to Identify Potential Biomarkers

  • Nadine Baroukh,
  • Nathan Canteleux,
  • Antoine Lefèvre,
  • Camille Dupuy,
  • Cécile Martias,
  • Antoine Presset,
  • Malayannan Subramaniam,
  • John R. Hawse,
  • Patrick Emond,
  • Philippe Pouletaut,
  • Sandrine Morandat,
  • Sabine F. Bensamoun,
  • Lydie Nadal-Desbarats

DOI
https://doi.org/10.3390/metabo12060556
Journal volume & issue
Vol. 12, no. 6
p. 556

Abstract

Read online

The transcription factor Krüppel-like factor 10 (Klf10), also known as Tieg1 for TGFβ (Inducible Early Gene-1) is known to control numerous genes in many cell types that are involved in various key biological processes (differentiation, proliferation, apoptosis, inflammation), including cell metabolism and human disease. In skeletal muscle, particularly in the soleus, deletion of the Klf10 gene (Klf10 KO) resulted in ultrastructure fiber disorganization and mitochondrial metabolism deficiencies, characterized by muscular hypertrophy. To determine the metabolic profile related to loss of Klf10 expression, we analyzed blood and soleus tissue using UHPLC-Mass Spectrometry. Metabolomics analyses on both serum and soleus revealed profound differences between wild-type (WT) and KO animals. Klf10 deficient mice exhibited alterations in metabolites associated with energetic metabolism. Additionally, chemical classes of aromatic and amino-acid compounds were disrupted, together with Krebs cycle intermediates, lipids and phospholipids. From variable importance in projection (VIP) analyses, the Warburg effect, citric acid cycle, gluconeogenesis and transfer of acetyl groups into mitochondria appeared to be possible pathways involved in the metabolic alterations observed in Klf10 KO mice. These studies have revealed essential roles for Klf10 in regulating multiple metabolic pathways whose alterations may underlie the observed skeletal muscle defects as well as other diseases.

Keywords